In a Business Report: The [San Francisco] Chronicle with Bloomberg post, John Lauerman says that "using faster, more accurate technologies, doctors are combing through ever-wider swaths of the human genome to pinpoint and counteract the causes of disease." According to the Dana-Farber Cancer Institute's Barrett Rollins, "cancer is among the most promising targets." Rollins tells Lauerman that genome screens are quickly becoming standard tests in the community, and adds, "if you're working at a cancer center and not thinking about this, you should be fired."
Bloomberg's Lauerman, a participant in the Personal Genome Project led by Harvard's George Church, says that while he "waited to see what my genome can reveal about my future health, I thought about whether I might face a heightened risk of cancer." Business Report adds that Lauerman's sequencing results will be detailed in future posts.